Mealer R, Williams S, Noel M, Yang B, DSouza A, Nakata T
Mol Psychiatry. 2022; 27(3):1405-1415.
PMID: 35260802
PMC: 9106890.
DOI: 10.1038/s41380-022-01490-1.
Mealer R, Jenkins B, Chen C, Daly M, Ge T, Lehoux S
Sci Rep. 2020; 10(1):13162.
PMID: 32753748
PMC: 7403432.
DOI: 10.1038/s41598-020-70108-9.
Jones C, Njomen E, Sjogren B, Dexheimer T, Tepe J
ACS Chem Biol. 2017; 12(9):2240-2247.
PMID: 28719185
PMC: 5720355.
DOI: 10.1021/acschembio.7b00489.
Green A, Aronson J
Br J Clin Pharmacol. 2012; 73(6):959-67.
PMID: 22360689
PMC: 3391528.
DOI: 10.1111/j.1365-2125.2012.04246.x.
Yadav P, Abbas A, Farrell M, Setola V, Sciaky N, Huang X
Neuropsychopharmacology. 2010; 36(3):638-51.
PMID: 21048700
PMC: 3055689.
DOI: 10.1038/npp.2010.195.
The role of dopamine in the antipsychotic effect and the pathogenesis of schizophrenia.
Crow T, Johnstone E, Longden A, Owen F, Riley G
Proc R Soc Med. 2010; 70(Suppl 10):15-9.
PMID: 20919312
PMC: 1542813.
2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors.
Engel G, Muller-Schweinitzer E, Palacios J
Naunyn Schmiedebergs Arch Pharmacol. 1984; 325(4):328-36.
PMID: 6728042
DOI: 10.1007/BF00504377.
Serotonin binds specifically and saturably to an actin-like protein isolated from rat brain synaptosomes.
Small D, Wurtman R
Proc Natl Acad Sci U S A. 1984; 81(3):959-63.
PMID: 6583691
PMC: 344959.
DOI: 10.1073/pnas.81.3.959.
Genetic regulation of neurotransmitter enzymes and receptors: relationship to the inheritance of psychiatric disorders.
Ciaranello R, BOEHME R
Behav Genet. 1982; 12(1):11-35.
PMID: 6124232
DOI: 10.1007/BF01065738.
Evidence for an inhibitory presynaptic component of neuroleptic drug action.
de Belleroche J, Bradford H
Br J Pharmacol. 1981; 72(3):427-33.
PMID: 6114766
PMC: 2071588.
DOI: 10.1111/j.1476-5381.1981.tb10993.x.
Halopemide, a new psychotropic agent. Cerebral distribution and receptor interactions.
Loonen A, Soudijn W
Pharm Weekbl Sci. 1985; 7(1):1-9.
PMID: 2984638
DOI: 10.1007/BF01962862.
Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperone.
Chivers J, Jenner P, Marsden C
Br J Pharmacol. 1987; 90(3):467-78.
PMID: 2882801
PMC: 1917179.
DOI: 10.1111/j.1476-5381.1987.tb11196.x.
Stereoselective activity of chiral neuroleptics.
White T, Schmutz J
Experientia. 1977; 33(10):1399.
PMID: 908433
DOI: 10.1007/BF01920205.
Effects of GABA, dopamine, and substance P on the release of newly synthesized 3H-5-hydroxytryptamine from rat substantia nigra in vitro.
Reubi J, Emson P, Jessell T, Iversen L
Naunyn Schmiedebergs Arch Pharmacol. 1978; 304(3):271-5.
PMID: 714184
DOI: 10.1007/BF00507968.
Shape change of blood platelets--a model for cerebral 5-hydroxytryptamine receptors?.
Graf M, Pletscher A
Br J Pharmacol. 1979; 65(4):601-8.
PMID: 435685
PMC: 1668678.
DOI: 10.1111/j.1476-5381.1979.tb07870.x.
Stereochemical specificity in the antipsychotic effects of flupenthixol in man [proceedings].
Crow T, Johnstone E
Br J Pharmacol. 1977; 59(3):466P.
PMID: 14758
PMC: 1667994.
